SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086896
Filing Date
2023-11-14
Accepted
2023-11-14 16:01:39
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_tffpharma.htm   iXBRL 10-Q 1034399
2 WARRANT DATED AUGUST 17, 2023 ISSUED TO THE BENCHMARK COMPANY, LLC f10q0923ex4-1_tffpharma.htm EX-4.1 78624
3 CERTIFICATION f10q0923ex31-1_tffpharma.htm EX-31.1 13827
4 CERTIFICATION f10q0923ex31-2_tffpharma.htm EX-31.2 17699
5 CERTIFICATION f10q0923ex32-1_tffpharma.htm EX-32.1 10559
6 GRAPHIC image_001.jpg GRAPHIC 2938
  Complete submission text file 0001213900-23-086896.txt   4315178

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE tffp-20230930.xsd EX-101.SCH 40660
8 XBRL CALCULATION FILE tffp-20230930_cal.xml EX-101.CAL 28641
9 XBRL DEFINITION FILE tffp-20230930_def.xml EX-101.DEF 177245
10 XBRL LABEL FILE tffp-20230930_lab.xml EX-101.LAB 356882
11 XBRL PRESENTATION FILE tffp-20230930_pre.xml EX-101.PRE 188799
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_tffpharma_htm.xml XML 432953
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39102 | Film No.: 231405666
SIC: 2834 Pharmaceutical Preparations